Want to see HK:0722 full AI Analyst Report?
0722 Stock Chart & Stats
HK$0.48
<HK$0.01(1.22%)
At close: 4:00 PM EST
HK$0.48
<HK$0.01(1.22%)
Day’s Range― - ―
52-Week RangeHK$0.45 - HK$0.55
Previous CloseN/A
Volume270.00K
Average Volume (3M)28.76K
Market Cap
HK$356.42M
Enterprise ValueHK$151.86M
Total Cash (Recent Filing)HK$378.41M
Total Debt (Recent Filing)HK$108.82M
Price to Earnings (P/E)10.9
Beta0.13
Next Earnings
Sep 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.1%
Share Statistics
EPS (TTM)0.04
Shares Outstanding810,955,260
10 Day Avg. Volume39,200
30 Day Avg. Volume28,758
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.51
Price to Sales (P/S)0.52
P/FCF Ratio2.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthConsistent and rising free cash flow provides durable internal funding for clinic upkeep, expansion, and dividends. Strong cash conversion in 2025 improves flexibility to invest in patient services or return capital without relying on external financing, supporting resilience over months.
Conservative Balance SheetLow, stable leverage reduces bankruptcy risk and preserves strategic optionality. With equity a sizable capital base and modest debt levels, the company can endure cyclical softness, pursue opportunistic investments, and sustain operations without heavy refinancing pressure over the medium term.
Healthy Gross MarginsA ~67% gross margin indicates structural pricing power or cost-efficient service delivery in outpatient and dental operations. Even with bottom-line compression, strong gross margins underpin the ability to regain operating leverage if revenues stabilize or management re-focuses on cost control over the coming months.
Bears Say
Net Margin CompressionA sharp drop in net margin signals structural pressure on profitability—higher operating costs, pricing pressure, or mix shift. Sustained lower margins reduce retained earnings, constrain reinvestment capacity and dividend sustainability unless operational fixes restore margin over the medium term.
Recent Revenue WeaknessA decline in revenue after previous growth suggests demand softness or competitive share loss in outpatient/dental services. If revenue erosion persists, it will limit operating leverage, hinder margin recovery, and pressure returns, making medium-term growth and cash-flow expansion harder to achieve.
Declining Return On EquityROE falling by more than half indicates the business is generating much lower returns on invested capital. Persistently weak ROE reduces shareholder value creation and limits the firm's ability to attract capital for strategic initiatives, implying structural profit recovery is needed.
UMP Healthcare Holdings Limited News
0722 FAQ
What was UMP Healthcare Holdings Limited’s price range in the past 12 months?
UMP Healthcare Holdings Limited lowest stock price was HK$0.45 and its highest was HK$0.55 in the past 12 months.
What is UMP Healthcare Holdings Limited’s market cap?
UMP Healthcare Holdings Limited’s market cap is HK$356.42M.
When is UMP Healthcare Holdings Limited’s upcoming earnings report date?
UMP Healthcare Holdings Limited’s upcoming earnings report date is Sep 17, 2026 which is in 75 days.
How were UMP Healthcare Holdings Limited’s earnings last quarter?
UMP Healthcare Holdings Limited released its earnings results on Feb 25, 2026. The company reported HK$0.024 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.024.
Is UMP Healthcare Holdings Limited overvalued?
According to Wall Street analysts UMP Healthcare Holdings Limited’s price is currently Overvalued.
Does UMP Healthcare Holdings Limited pay dividends?
UMP Healthcare Holdings Limited pays a Semiannually dividend of HK$0.014 which represents an annual dividend yield of 7.1%. See more information on UMP Healthcare Holdings Limited dividends here
What is UMP Healthcare Holdings Limited’s EPS estimate?
UMP Healthcare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UMP Healthcare Holdings Limited have?
UMP Healthcare Holdings Limited has 810,955,260 shares outstanding.
What happened to UMP Healthcare Holdings Limited’s price movement after its last earnings report?
UMP Healthcare Holdings Limited reported an EPS of HK$0.024 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.289%.
Which hedge fund is a major shareholder of UMP Healthcare Holdings Limited?
Currently, no hedge funds are holding shares in HK:0722
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UMP Healthcare Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.61%
12-Months-Change
Fundamentals
Return on Equity
4.28%
Trailing 12-Months
Asset Growth
-0.47%
Trailing 12-Months
Company Description
UMP Healthcare Holdings Limited
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution Services and Clinical Healthcare Services. Its extensive service portfolio encompasses virtual medical support, general family practice, and specialized consultations covering diverse fields like internal medicine, surgery, pediatrics, cardiology, dermatology, ENT, orthopedics, ophthalmology, urology, gastroenterology, endocrinology, and diabetes. Additionally, it provides comprehensive dental services, including implants, cosmetic procedures, periodontal care, and orthodontics, alongside traditional Chinese medicine. The company further extends its offerings to include physiotherapy, addressing muscle strengthening, limb and hand function, and eye-hand coordination. Other key services feature day surgery and endoscopy, advanced diagnostic imaging and laboratory testing, health assessments, visa-required medical examinations, immunization and advisory services, vision correction and optometry, reconstructive and aesthetic surgeries (plastic, head, and neck), dermatological and cosmetic treatments, ongoing chronic disease management, and COVID-19 screening. Furthermore, UMP Healthcare is involved in delivering training and advisory services within the healthcare sector. Its client base includes insurance providers, corporate clients, and individual self-paying patients. The organization maintains a vast network of roughly 1,100 directly owned and partnered service facilities. Established in 1990, UMP Healthcare Holdings Limited has its main offices situated in Central, Hong Kong.
Technical Analysis
Yonghe Medical Group Co., Ltd.
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Concord Healthcare Group Co., Ltd. Class H
―